During the past decade, Stanford Medicine Ophthalmology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stanford Medicine Ophthalmology" are "Branch Retinal Vein Occlusion" (2 trials), "Central Serous Retinopathy With Pit of Optic Disc" (2 trials), "Commotio Retinae" (2 trials), "Epiretinal Membrane" (2 trials) and "Radiation Retinopathy" (2 trials). Many other conditions were trialed in "Stanford Medicine Ophthalmology" in a lesser frequency.

Most popular intervention types in "Stanford Medicine Ophthalmology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Episcleral Dexamethasone" (2 trials) and "Episcleral Celecoxib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford Medicine Ophthalmology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Stanford Medicine Ophthalmology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Stanford Medicine Ophthalmology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stanford Medicine Ophthalmology, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".